Apexigen Stock

apexigen.comHealthcareFounded: 1900Funding to Date: $165.38MM

Apexigen is a clinical-stage biopharmaceutical company discovering and developing innovative immuno-oncology therapeutics generated by APXiMAB™, the Company’s proprietary antibody drug discovery platform.

Register for Details

For more details on financing and valuation for Apexigen, register or login.

Please provide your first name.
Please provide your last name.
Please provide a valid email address.

By registering, you agree to the Forge Terms of Use. Already registered? Click here to log in

Enterprise Value (based on primary financings)

Enterprise Value

View Enterprise Value for Apexigen.

Register Today

Team

Management Team

Amy Wong
Vice President, Finance
Ovid Trifan MD
Chief Medical Officer
Xiaodong Yang Ph.D
Chief Executive Officer, President and Board Member
Mark Nevins
Vice President of Business Development
Frances Rena Bahjat Ph.D
Vice President of Discovery Research

Board Members

Herb Cross
William Rutter Ph.D
Dan Zabrowski Ph.D
Decheng Capital
George Lee Ph.D
Amkey Ventures
Xiaodong Yang Ph.D
Karen Liu Ph.D
3E Bioventures Capital
Kenneth Fong Ph.D
Kenson Ventures

Other companies like Apexigen in the Healthcare sector

Sector
Last Round Est. Valuation
$3.6B
Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$150MM
Sector
Last Round Est. Valuation
$4.8B
Sector
Last Round Est. Valuation
$1.08B
Sector
Last Round Est. Valuation
$296.3MM